WORLAND STEPHEN T (President and Chief Executive) purchased 10.3% of their position (20K shares) of EFFECTOR THERAPEUTICS, INC. on the open market
Open‑market purchase worth $27.4K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/9/2022ACC: 0001209191-22-035277
DirectorOfficer· President and Chief Executive
Since Aug 2021
+20K
Net shares
Net buyer
$27.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$1.37
Trade value
$27.40K
% of position
10.3%
6/7/2022
194.98K→214.98K
Total
Net shares
+20K
Net value
$27.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/7/2022 | P · Purchase | +20K | $1.37 | $27.40K | 10.3% | 194.98K | 214.98K |
| Total | +20K | $27.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned562.34K
Total
562.34K indirect562.34K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 562.34K | Indirect |
| Total | 562.34K | 562.34K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported